The White House is expected to announce a deal this week with Eli Lilly and Novo Nordisk that would lower the price of their popular obesity drugs to $149 per month in some cases, according to three ...
Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A ...
US-based medicine company Eli Lilly to invest $3B in a new manufacturing facility in the Netherlands to expand production and create jobs.
Insulin costs have declined over the past two years, and additional price cuts are expected in 2026. Medicare will lower prices for several diabetes drugs, including Januvia and Jardiance. Federal and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results